Biomedical subjects

M Sebban

Publications and source records attributed to M Sebban.

3 recordsLinked to original sources

PubMed2002

A data-mining approach to spacer oligonucleotide typing of Mycobacterium tuberculosis.

MOTIVATION: The Direct Repeat (DR) locus of Mycobacterium tuberculosis is a suitable model to study (i) molecular epidemiology and (ii) the evolutionary genetics of tuberculosis. This is achieved by a DNA analysis technique (genotyping), called sp acer oligo nucleotide typing (spoligotyping ). In this paper, we investigated data analysis methods to discover intelligible knowledge rules from spoligotyping, that has not yet been applied on such representation. This processing was achieved by applying the C4.5 induction algorithm and knowledge rules were produced. Finally, a Prototype Selection (PS) procedure was applied to eliminate noisy data. This both simplified decision rules, as well as the number of spacers to be tested to solve classification tasks. In the second part of this paper, the contribution of 25 new additional spacers and the knowledge rules inferred were studied from a machine learning point of view. From a statistical point of view, the correlations between spacers were analyzed and suggested that both negative and positive ones may be related to potential structural constraints within the DR locus that may shape its evolution directly or indirectly. RESULTS: By generating knowledge rules induced from decision trees, it was shown that not only the expert knowledge may be modeled but also improved and simplified to solve automatic classification tasks on unknown patterns. A practical consequence of this study may be a simplification of the spoligotyping technique, resulting in a reduction of the experimental constraints and an increase in the number of samples processed.

Algorithms↗

PubMed2000

Dual behavior of 4-aza-6-nitrobenzofuroxan. A powerful electrophile in hydration and sigma-complex formation and a potential dienophile or heterodiene in diels-alder type reactions

In investigating the reactivities of aza analogues of super-electrophile 4,6-dinitrobenzofuroxan (DNBF, 1), we have found that the nitro-substituted pyridofuroxan 2 gives a remarkably stable hydrate 3 in aqueous solution (as evidenced by the requirement of ca. 50% H(2)SO(4) (H(0) approximately -3) for complete recovery of 2). The equilibrium constant K(H)()2(O) for hydration of 2 is estimated to be >/= 100, being comparable only with the K(H)()2(O) values reported for hydration of highly activated neutral polyazaaromatics such as 2- and 6-hydroxypteridines or 7-azapteridine. Interestingly, the NH group of 3 undergoes ionization at rather low pH (p = 5.79), affording an anionic hydroxy sigma-adduct 4 which is thermodynamically 10(8) times more stable than the related sigma-adduct of pteridine. The experimental evidence is that 4 is slightly more stable than the hydroxy sigma-adduct of DNBF, indicating not only that 2 ranks among the most electrophilic heteroaromatics known to date but also than an aza group may in fact be as efficient as a nitro group in promoting sigma-complex formation. 2 is also found to be a versatile Diels-Alder reagent, as a result of the low aromatic character of its six-membered ring. Upon treatment of 2 with cyclopentadiene and 2,3-dimethylbutadiene, various reactivity patterns have been observed. These led to different cycloadducts arising from normal as well as inverse electron-demand condensations involving the pyridine ring as the dienophile or the heterodiene contributor. Altogether, the results reveal major differences between the reactivity of 2 and that of DNBF, with in particular a remarkable tendency of the pyridofuroxan adducts to undergo covalent hydration, resulting in the formation of stable carbinolamines. Also noteworthy is the characterization of a diadduct which results from a Diels-Alder trapping of the o-dinitroso intermediate involved in the exchange of the 1-oxide and 3-oxide tautomers of 2.

Journal Article↗

PubMed1978

[The effects of phenylbutazone on the decrease of lithium clearance].

During the treatment of a manic depressive patient, the authors reported some lithium toxicity signs, as lithium carbonate (3 X 300 mg p.d.) and phenylbutazone suppository (3 X 250 mg/p.d.) were associated, this last medication being prescribed for a phlebitis. Lithiemia increased from .70 to 1,44 mEq/l., the lithiemia clearance falling from 10 ml to 5 ml/mn/1.73 m2) and the lithium tubular reabsorption percentage increasing from 85 to 94% (standard rates: 77.4 +/- 1.3%). In a second time, a rat experimentation corroborated these findings: phenylbutazone treatment (100 mg/kg/p.o. for five days) resulted in a lithium tubular reabsorption increase. It seems that the association of lithium carbonate with phenylbutazone should be avoided. The authors point out the risk of prescribing lithium and pyrazolic by-products as phenylbutazone, which are potentially nephrotoxic.

Animals↗